Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 38.16% | -24.28% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -24.66% | -- | |||
| Total Operating Expenses | 22.23% | -7.10% | |||
| Operating Income | -22.23% | 7.10% | |||
| Income Before Tax | -22.23% | 7.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.23% | 7.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.23% | 7.10% | |||
| EBIT | -22.23% | 7.10% | |||
| EBITDA | -22.55% | 7.19% | |||
| EPS Basic | -21.21% | 5.71% | |||
| Normalized Basic EPS | -19.05% | 4.55% | |||
| EPS Diluted | -21.21% | 5.71% | |||
| Normalized Diluted EPS | -19.05% | 4.55% | |||
| Average Basic Shares Outstanding | 0.29% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||